English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/134377
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry

AutorPessoa de Magalhães, Roberto J.; Vidriales, Maria Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lécrevisse, Quentin; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M. ; Pérez-Andrés, Martin; Lahuerta, Juan José; San Miguel, Jesús F. ; Orfao, Alberto
Fecha de publicación2013
EditorFerrata Storti Foundation
CitaciónHaematologica 98(1): 79-86 (2013)
ResumenMultiple myeloma remains largely incurable. However, a few patients experience more than 10 years of relapsefree survival and can be considered as operationally cured. Interestingly, long-term disease control in multiple myeloma is not restricted to patients with a complete response, since some patients revert to having a profile of monoclonal gammopathy of undetermined significance. We compared the distribution of multiple compartments of lymphocytes and dendritic cells in the bone marrow and peripheral blood of multiple myeloma patients with long-term disease control (n=28), patients with newly diagnosed monoclonal gammopathy of undetermined significance (n=23), patients with symptomatic multiple myeloma (n=23), and age-matched healthy adults (n=10). Similarly to the patients with monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma, patients with long-term disease control showed an expansion of cytotoxic CD8 + T cells and natural killer cells. However, the numbers of bone marrow T-regulatory cells were lower in patients with long-term disease control than in those with symptomatic multiple myeloma. It is noteworthy that B cells were depleted in patients with monoclonal gammopathy of undetermined significance and in those with symptomatic multiple myeloma, but recovered in both the bone marrow and peripheral blood of patients with long-term disease control, due to an increase in normal bone marrow B-cell precursors and plasma cells, as well as pre-germinal center peripheral blood B cells. The number of bone marrow dendritic cells and tissue macrophages differed significantly between patients with long-term disease control and those with symptomatic multiple myeloma, with a trend to cell count recovering in the former group of patients towards levels similar to those found in healthy adults. In summary, our results indicate that multiple myeloma patients with long-term disease control have a constellation of unique immune changes favoring both immune cytotoxicity and recovery of B-cell production and homing, suggesting improved immune surveillance.
DescripciónSpanish Myeloma Group (GEM) and Grupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groups: et al.
Versión del editorhttp://dx.doi.org/10.3324/haematol.2012.067272
URIhttp://hdl.handle.net/10261/134377
DOI10.3324/haematol.2012.067272
Identificadoresdoi: 10.3324/haematol.2012.067272
issn: 0390-6078
e-issn: 1592-8721
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
flowcytometry.pdf2,56 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.